OriGene Logo

Customer Login

Checkout as a new customer

Creating an account has many benefits:

  • See order and shipping status
  • Track order history
  • Check out faster
Create an Account

Tissue Total RNA, Colon: rectosigmoid

Be the first to review this product
SKU
CR560136
RNA (5 µg); Colon: rectosigmoid; Within normal limits
  $370.00
2 Weeks*

Frequently Bought Together (4)

HP205798 qSTAR qPCR primer pairs against Homo sapiens gene GAPDH 200 reactions
$150.00
MP205604 qSTAR qPCR primer pairs against Mus musculus gene Gapdh 200 reactions
$150.00
HCRT103 24 matched pairs (48 samples) covering 24-normal, 5-Stage I, 5-IIA, 2-IIB, 2-IIIA, 3-IIIB, 2-IIIC, 1-III, 4-IV. Available in 2, 5, 10 identical plates.
2 Panels
$1,060.00
HMRT104 48 samples covering all major human normal tissues at different locations. Available in 2, 5, 10 identical plates.
2 Panels
$850.00
Specifications
Specifications
Product Data
Disease State Normal
Diagnosis Category Normal
Sample ID FR0002757A
Case ID CI0000009999
Prep 1
Vial ID RN0000152C
Tissue of Origin Colon: rectosigmoid
Site of Finding Colon: rectosigmoid
Appearance Normal
Sample Diagnosis (from Pathology Verification) Within normal limits
Normal 100%
Lesional 0%
Tumor 0%
Tumor Hypo/Acellular Stroma 0%
Tumor Hypercellular Stroma 0%
Necrosis 0%
Pathology Verification notes from H&E review 85% mucosa, 5% submucosa, 10% muscle
T (Extent of Primary Tumor) Not applicable
N (Lymph node metastasis) Not applicable
M (Distant metastasis) Not applicable
CASE Diagnosis (from medical center path report) Adenocarcinoma of colon
Age 38
Gender Male
Tumor Grade Not applicable
Minimum Stage Grouping Not applicable
Storage Store tissue total RNA at -80°C.
Stability These products are stable for one year from date of shipping when stored at -80°C without repeated freeze/thaws.
Shipping Dry Ice
Reviews
Write Review
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapy
Penrose, Iftikhar, Collins et al
Sci Rep (2021) 11 (1), 9010 DOI: 10.1038/s41598-021-88489-w
Cited by 37
AI Summary: OriGene products contributed to this study by providing colonic mucosal tissue RNA samples (IDs: CR561752, CR562039, CR562979, CR561525, CR560265, CR560498) used to validate differentially expressed gene signatures identified in ulcerative colitis patients.
Snippet: or therapy responders. Primary UC tissue RNA sources Colonic mucosal tissue biopsies for validation of transcript expression were obtained from actively inflamed tissue sections of patients with UC (Origene Technologies;ID: CR561752, CR562039, CR562979, CR561525, CR560265) and from normal colonic mucosal biopsies of patients who underwent colon cancer screening or tissue removal (ID: CR560498, C
FigureFigureFigure
Showing 1-1 of 1 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products